Next Article in Journal
Oral Immunization with Recombinant Saccharomyces cerevisiae Expressing Viral Capsid Protein 2 of Infectious Bursal Disease Virus Induces Unique Specific Antibodies and Protective Immunity
Previous Article in Journal
The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Brief Report

COVID-19 Vaccine Confidence Mediates the Relationship between Health Literacy and Vaccination in a Diverse Sample of Urban Adults

1
Section of General Internal Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02119, USA
2
Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
3
Department of Medicine, Tufts University School of Medicine, Tufts Medical Center, Boston, MA 02116, USA
4
Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(12), 1848; https://doi.org/10.3390/vaccines11121848
Submission received: 9 November 2023 / Revised: 1 December 2023 / Accepted: 8 December 2023 / Published: 13 December 2023
(This article belongs to the Section COVID-19 Vaccines and Vaccination)

Abstract

:
We sought to analyze the relationship between health literacy, confidence in COVID-19 vaccines, and self-reported vaccination. We hypothesized that the relationship between health literacy and vaccination would be mediated by vaccine confidence. We recruited (N = 271) English- and Spanish-speaking adults in Boston and Chicago from September 2018 to September 2021. We performed a probit mediation analysis to determine if confidence in COVID-19 vaccines and health literacy predicted self-reported vaccination. We hypothesized that the relationship between health literacy and vaccination would be mediated by vaccine confidence. Participants were on average 50 years old, 65% female, 40% non-Hispanic Black, 25% Hispanic, and 30% non-Hispanic White; 231 (85%) reported at least one COVID-19 vaccination. A higher mean vaccine confidence score (t = −7.9, p < 0.001) and higher health literacy (t = −2.2, p = 0.03) were associated with vaccination, but only vaccine confidence predicted vaccination in a multivariate model. Vaccine confidence mediated the relationship between health literacy and COVID-19 vaccination (mediated effects: 0.04; 95% CI [0.02, 0.08]). We found that using a simple tool to measure vaccine confidence identified people who declined or delayed COVID-19 vaccination in a diverse sample of adults with varying levels of health literacy. Simple short survey tools can be useful to identify people who may benefit from vaccine promotion efforts and evidence-based communication strategies.

1. Introduction

Despite the extensive evidence for COVID-19 vaccine effectiveness [1,2], vaccine promotion efforts [3], and broad vaccine availability, vaccination rates continue to be below optimal [4,5]. Concurrently, there are disparities in COVID-19 vaccination rates across different sociodemographic groups [6,7,8] and rural compared to urban regions [9,10,11]. These trends have persisted and will influence future pandemics [12,13].
Many factors influence vaccination acceptance, including confidence in efficacy and safety, the perception of risks and benefits, and availability, as well as political, cultural, and religious factors [14,15,16]. Vaccine confidence is defined as the degree of trust individuals have in a specific vaccine and the health care system recommending vaccination [17]. Not surprisingly, lower vaccine confidence is associated with a lower likelihood of vaccination [18,19]. Confidence also influences vaccine hesitancy [20], a behavioral state inclusive of both complete vaccine refusal and delays in vaccination [14]. Given the potential of alienating individuals with uncertainly around vaccination, shifting public health focus away from hesitancy and towards confidence may be less stigmatizing to individuals with vaccination concerns [21,22]. Additionally, interventions to increase vaccine confidence can emphasize the role of individual decision making through empathetic patient-centered discussions of risks and benefits, rather than focusing on reducing a less desirable state (i.e., hesitancy) [23].
Various tools have been used to measure vaccine confidence. The Vaccine Confidence Index (VCI; www.vaccineconfidence.org) measures individual perceptions of vaccine efficacy and safety [24] and has been adapted to different settings and infectious diseases [25,26,27]. Given the factors associated with lower vaccine uptake vary by community and region [28], measuring vaccine confidence in different settings can help to identify communities that may benefit from vaccine education interventions and outreach. In addition, understanding measures of vaccine confidence that perform well in diverse samples will also inform surveillance efforts [29]. Vaccination experts have called for improving the scientific understanding of the determinants of confidence and trust in vaccines, emphasizing that scientific inquiry into these factors is as important as studies that evaluate the efficacy and safety of vaccines themselves [30]. Health literacy has been defined as an individual’s ability to find, understand, and use information to inform their health decisions [31]. Health literacy has previously been shown to be related to vaccination attitudes [32,33]. We have previously shown that low health literacy was associated with low vaccine confidence. Specifically, health literacy mediated the relationship between race and ethnicity, and vaccine confidence [34]. Here, we assessed the relationship between health literacy, vaccine confidence, and vaccination. We hypothesized that higher health literacy and vaccine confidence would be associated with higher vaccination, and that confidence would mediate the relationship between health literacy and vaccination.

2. Materials and Methods

Our methods have been previously described [34].

2.1. Setting, Recruitment, and Population

Data for this analysis were collected within a parent study that sought to evaluate if health literacy impacts the psychometric properties of frequently used health questionnaires (clinical trial number: NCT03584490). Potential participants were adults in Boston and Chicago, recruited through community-based outreach and promotion on Research Match (www.researchmatch.org). Eligibility included an age of 18+ years; Spanish or English speaking; and ability to provide informed consent. Following informed consent procedures, participants were interviewed at baseline, 3 months, and 6 months by bilingual research staff. Participants were remunerated for participation.
At a baseline in-person visit (September 2018–March 2020), participants were characterized in terms of demographics, health literacy, and other screening measures. After the onset of the COVID-19 pandemic, visits were conducted via phone (April 2021–September 2021). Participants completed multiple health questionnaires during phone visits of a 60–90 min duration. The sample was restricted to English and Spanish speakers as these are the two most common languages spoken in the geographic regions of the study and given that the study assessment tools were validated in these two languages. Individuals with impairments in cognition, vision, or hearing that would prevent the completion of survey questionnaires were excluded from participation. Procedures were approved by Northwestern and Boston University Medical Center’s Institutional Review Boards.

2.2. Variables

At baseline, self-reported demographic data including age, gender, race and ethnicity, preferred language, and education level were collected. We assessed health literacy using Health Literacy Assessment Using Talking Touchscreen Technology (Health LiTT), which is a self-administered, computerized, performance-based measure that has been validated in English and Spanish and is scored on a T-score scale [35,36,37]. Higher scores indicate higher levels of overall health literacy. Health LiTT assesses performance-based health literacy skills including prose, document, and quantitative literacy.
Vaccine confidence was assessed at baseline, 3 months, and 6 months using an adapted, eight-item VCI (aVCI) [25]. The adapted VCI was inspired by the Global Vaccine Confidence Index, a survey-based measure of confidence in immunizations used extensively in global samples [15,24,38]. The adapted VCI is a more focused survey including eight Likert-style questions related to vaccination views (aVCI text, Appendix A). Respondents chose their level of agreement with responses (totally agree to totally disagree) with a score range of 0.25–4.0. Higher scores on the aVCI indicate a higher ratio of vaccine confidence to vaccine-related concerns. We measured vaccination status at 6 months using one item, “Have you received at least one dose of a vaccine for COVID-19?” with a Yes/No response. Vaccinations became available in the study areas in April 2021 [39,40,41].

2.3. Analysis

Data analyses were completed in R (v4.2.2) and Mplus (v8.9). For the analyses, race and ethnicity were categorized into 4 groups as White Non-Hispanic and other (including participants designating themselves as more than one race), Asian Non-Hispanic, Black Non-Hispanic, or Hispanic/LatinX. Education was categorized as (1) 12th grade-equivalent or less, (2) some college level education (incomplete) or an associate or technical degree, or (3) a college degree or higher level of education.
We compared aVCI and health literacy scores for participants who were vaccinated and those who were not using two sample t-tests. A probit mediation analysis in Mplus [42] was used to test if baseline vaccine confidence mediated the relationship between health literacy and vaccination. Maximum likelihood estimation with bootstrapping (5000 iterations) and Monte Carlo integration were used for the mediation analysis. We hypothesized that health literacy would predict higher odds of vaccination, and that this relationship would be mediated by vaccine confidence.
To account for the possibility of non-random missing data for vaccine confidence (i.e., where skipped items indicate lower vaccine confidence), the analysis was repeated with ‘missingness’ as a covariate, defined as Yes/No for participants who skipped any aVCI items. We hypothesized that skipping items would predict a lower probability of vaccination. To examine potential changes in confidence over time, we conducted a latent growth curve analysis with health literacy measured at baseline and vaccine confidence at baseline, 3 months, and 6 months. We hypothesized that increases in the intercept and slope of vaccine confidence would predict vaccination. The results of the missingness analysis are included in our supplemental files.

3. Results

3.1. Sample

Of the total sample (N = 302), 31 participants did not provide vaccination status and were excluded, resulting in an analytic sample of 271 participants (Table 1). The sample was predominantly female (65.0%) and non-Hispanic (74.8%) with a mean age of 50.2 years (±16.2). No participants identified as transgender or non-binary. Most participants identified as either Black (39.5%) or White (29.5%) and had at least some college education (61.6%). Mean (SD) health literacy was 53.5 ± 8.5 (T score units; a score of 55 is the cutoff for adequate health literacy). The mean (SD) baseline aVCI ratio score was 2.4 ± 1.0. Most participants (85.2%) reported being vaccinated. Participants who reported vaccination had higher aVCI (p < 0.001, d = 1.3) and higher health literacy (p = 0.030, d = 0.4; Figure 1) scores. There were statistically significant differences in vaccination for Black participants compared to White participants (not vaccinated: 62.5% Black vs. 12.5% White; p < 0.001; d = 0.5).

3.2. Vaccination Prediction

In univariate analyses, both vaccine confidence and health literacy predicted vaccine acceptance. The association between vaccine confidence and vaccination was positive, such that higher confidence scores were associated with higher odds of vaccination. Health literacy was not a significant predictor of vaccination, after controlling for vaccine confidence (Table 2). In path analysis, vaccine confidence mediated the relationship between health literacy and vaccination (Table 2, Figure 2). In the latent growth curve analysis, a change in vaccine confidence was not a significant predictor of vaccination (Table 3). Missing any responses on the aVCI also did not predict vaccination (results included in Supplemental Files, Table S1).

4. Discussion

In a sample of diverse adults in Boston and Chicago, COVID-19 vaccination differed according to race, ethnicity, and health literacy. Vaccine confidence predicted vaccination and completely mediated the association between health literacy and vaccination. These results combined with those of an earlier study [34] demonstrate that health literacy is an important driver of vaccine confidence, but that a measure of confidence is a more specific predictor of vaccination. This result is consistent with findings from other studies demonstrating that vaccine-specific literacy and perceived health status may be the most important predictors of vaccination [43,44]. Thus, using simple measures of vaccine literacy or vaccine confidence can provide actionable information to tailor interventions towards increasing vaccination among populations at risk for disparities, including individuals with varying health literacy levels.
Strategic assessments of vaccine confidence can help public health entities anticipate evolving infectious disease threats and address the infodemic of misinformation that contributes to low vaccine confidence [45]. Vaccine confidence has been shown to evolve over time even among people who have previously accepted vaccinations [46,47]. Although we did not identify a relationship between vaccine confidence over time and vaccination, the short duration of our follow up may have reduced our ability to detect differences.
Vaccine confidence may provide information about health behaviors beyond the likelihood of accepting a specific vaccination [48]. Vaccine confidence for one vaccine may predict low confidence for others [49]. In addition, low confidence has been associated with susceptibility to misinformation, lower trust in health care, and other negative health consequences [50,51]. Accurately tracking vaccine confidence in diverse communities will inform public health efforts to design more effective strategic and targeted interventions that improve vaccination uptake.
Efforts to increase vaccine confidence through education campaigns, health care provider training, and strategies to counteract misinformation are needed [52,53]. Collaboration with community partners like faith-based organizations have been shown to be effective [54]. Given that health literacy is an antecedent of vaccine confidence [34], interventions to improve health literacy may be an essential component of efforts that reduce susceptibility to misinformation [55,56] and increase vaccine confidence. Specifically, the development and evaluation of interventions that increase media health literacy are greatly needed due to the volume of conflicting information about the COVID-19 virus and vaccination [57,58,59].
Our study had limitations. The sample size calculations were designed around the primary outcome of the parent study, defined as the differential functioning of health questionnaires. The analysis presented here is a secondary analysis of an outcome measure added during the COVID-19 pandemic, and thus, results should be interpreted with caution. We assessed self-reported vaccination, increasing the possibility of social desirability bias. However, our analysis showing that aVCI missingness did not change our findings supports their robustness. Our sample recruited urban English and Spanish speakers and thus, the results may not be generalizable to other populations. Data collection in additional populations is needed. The health literacy measure used in this study, Health LiTT, is a test-based measure of functional health literacy; it does not measure other dimensions of health literacy relating to constructs such as information seeking and behavioral interaction. Potentially, dimensions of health literacy not examined in this analysis would be stronger predictors of vaccine acceptance. For example, media literacy is likely to have significant relevance during the COVID-19 pandemic given the abundance of online information about COVID-19 vaccines and treatments [60]. Finally, some have advocated for measures of vaccine confidence to assess health care trust at the system and provider levels [16,27]. The aVCI tool we used was brief, specific to COVID-19, and did not provide such an assessment. Incorporating measures of trust should be considered in future research.

5. Conclusions

The analysis described here identified significant differences in COVID-19 vaccine acceptance by race, ethnicity, and health literacy. However, the association between health literacy and COVID-19 vaccine acceptance is entirely mediated by vaccine confidence scores. Thus, we found that using a simple tool to measure vaccine confidence identified people who declined or delayed COVID-19 vaccination in a diverse sample of adults with varying levels of health literacy. This implies that simple short survey tools can be useful to identify people who may benefit from directed vaccine promotion efforts and evidence-based communication strategies. Assessments of vaccine confidence can be conducted to improve public health surveillance and facilitate strategies that increase confidence and vaccination, particularly for communities affected by health disparities.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/vaccines11121848/s1. Table S1: Mediation model estimates with missingness including direct and indirect effects.

Author Contributions

All authors were involved in the interpretation of findings and participated in manuscript preparation and approval. Conceptualization: J.W.G., M.K.P.-O. and E.A.H.; methodology: E.H., F.R.F., E.A.H., P.M., J.W.G. and M.K.P.-O.; formal analysis: F.R.F. and J.W.G.; investigation: L.E.H., C.W., M.M., E.S. and J.T.; resources: L.E.H., C.W., M.M., E.S. and J.T.; data curation: L.E.H., C.W., M.M., E.S. and J.T.; writing—original draft: E.H. and F.R.F.; writing—review and editing: E.H., F.R.F., M.K.P.-O., E.A.H., L.E.H., P.M., C.W., M.M., E.S., J.T. and J.W.G.; visualization: E.H. and F.R.F.; funding acquisition: J.W.G. and M.K.P.-O. All authors have read and agreed to the published version of the manuscript.

Funding

The research was funded by the National Institute of Health’s National Institute on Minority Health and Health Disparities (NIMHD), grant number 5R01MD010440-05.

Institutional Review Board Statement

The Institutional Review Boards at Northwestern University (Protocol NU STU00204308; initial approval: 30 November 2016) and Boston University School of Medicine (Protocol H-36349; initial approval: 1 December 2017) approved this study.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The authors have included the primary data used for this analysis, as well as Supplementary Files describing the analytic procedures and statistical code.

Acknowledgments

We would like to thank the participants in this study, as well as the extended study teams at Northwestern University and Boston University School of Medicine.

Conflicts of Interest

J.W.G. declares that he and his lab received a research grant from Pfizer to create a patient decision aid for children with atopic dermatitis (unrelated to this manuscript and unrelated to vaccines, vaccine confidence, and COVID-19); Pfizer is a maker of one common COVID-19 vaccine (Pfizer-BioNTech). He and his lab also have funding for research from the National Institutes of Health and the National Eczema Association. He has no other interests to declare. M.P.O. is a primary investigator in multiple National Institutes of Health-funded research projects. The other authors certify that they have no other affiliations with or involvement in any organization or entity with any financial interests (such as honoraria, educational grants, participation in speakers’ bureaus, memberships, employment, consultancies, stock ownership, or other equity interest, and expert testimonies or patent-licensing arrangements), or non-financial interests (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript. The other authors have no conflicts of interest to disclose. The study funder had no role in the design, collection, analysis, interpretation, or preparation of the manuscript or its submission for publication.

Appendix A

We include the questions of the adapted Vaccine Confidence Index (aVCI) and the scoring algorithm in Appendix A.
Adapted Vaccine Confidence Index Scale
  • COVID-19 is a serious illness. (A1)
  • COVID-19 vaccines are effective. (A2)
  • Healthcare workers must get vaccinated. (A3)
  • By getting vaccinated I protect people close to me from COVID-19. (A4)
  • It is better to contract COVID-19 than to get the vaccination. (B1)
  • COVID-19 vaccines have serious side effects. (B2)
  • COVID-19 vaccines can cause COVID-19 infection. (B3)
  • I am opposed to vaccination. (B4)
Scoring of Adapted VCI
The scoring algorithm for the VCI was implemented in R and calculates the aVCI score as follows: mean(A1, A2, A3, A4)/mean(B1, B2, B3, B4). The VCI was only calculated if 7 or 8 items were present. Prorating was accomplished using the na.rm = TRUE argument of the mean() function of base R. If fewer than 7 items were completed, the participant case was not included in the analysis.

References

  1. Lopez Bernal, J.; Andrews, N.; Gower, C.; Robertson, C.; Stowe, J.; Tessier, E.; Simmons, R.; Cottrell, S.; Roberts, R.; O’Doherty, M.; et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on COVID-19 related symptoms, hospital admissions, and mortality in older adults in England: Test negative case-control study. BMJ 2021, 373, n1088. [Google Scholar] [CrossRef] [PubMed]
  2. Moghadas, S.M.; Vilches, T.N.; Zhang, K.; Wells, C.R.; Shoukat, A.; Singer, B.H.; Meyers, L.A.; Neuzil, K.M.; Langley, J.M.; Fitzpatrick, M.C.; et al. The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States. Clin. Infect Dis. 2021, 73, 2257–2264. [Google Scholar] [CrossRef] [PubMed]
  3. Slaoui, M.; Hepburn, M. Developing Safe and Effective Covid Vaccines—Operation Warp Speed’s Strategy and Approach. N. Engl. J. Med. 2020, 383, 1701–1703. [Google Scholar] [CrossRef] [PubMed]
  4. Hughes, M.M.; Wang, A.; Grossman, M.K.; Pun, E.; Whiteman, A.; Deng, L.; Hallisey, E.; Sharpe, J.D.; Ussery, E.N.; Stokley, S.; et al. County-Level COVID-19 Vaccination Coverage and Social Vulnerability—United States, 14 December 2020–1 March 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 431–436. [Google Scholar] [CrossRef] [PubMed]
  5. Cuadros, D.F.; Miller, F.D.; Awad, S.; Coule, P.; MacKinnon, N.J. Analysis of vaccination rates and new COVID-19 infections by US county, July–August 2021. JAMA Netw. Open 2022, 5, e2147915. [Google Scholar] [CrossRef]
  6. Kolbe, A. Disparities in COVID-19 vaccination rates across racial and ethnic minority groups in the United States. Off. Assist. Secr. Plan. Eval. US Dep. Health Hum. Serv. 2021, 1522–1527. [Google Scholar]
  7. Pingali, C.; Meghani, M.; Razzaghi, H.; Lamias, M.J.; Weintraub, E.; Kenigsberg, T.A.; Klein, N.P.; Lewis, N.; Fireman, B.; Zerbo, O.; et al. COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics—Eight Integrated Health Care Organizations, United States, 14 December 2020–15 May 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 985–990. [Google Scholar] [CrossRef]
  8. Lopez, L., 3rd; Hart, L.H., 3rd; Katz, M.H. Racial and Ethnic Health Disparities Related to COVID-19. JAMA 2021, 325, 719–720. [Google Scholar] [CrossRef]
  9. Murthy, B.P.; Sterrett, N.; Weller, D.; Zell, E.; Reynolds, L.; Toblin, R.L.; Murthy, N.; Kriss, J.; Rose, C.; Cadwell, B.; et al. Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties—United States, 14 December 2020–10 April 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 759–764. [Google Scholar] [CrossRef]
  10. Mathieu, E.; Ritchie, H.; Ortiz-Ospina, E.; Roser, M.; Hasell, J.; Appel, C.; Giattino, C.; Rodés-Guirao, L. A global database of COVID-19 vaccinations. Nat. Hum. Behav. 2021, 5, 947–953. [Google Scholar] [CrossRef]
  11. Sallam, M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef]
  12. Lu, P.J.; Zhou, T.; Santibanez, T.A.; Jain, A.; Black, C.L.; Srivastav, A.; Hung, M.C.; Kriss, J.L.; Schorpp, S.; Yankey, D.; et al. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults—United States, November–December 2022. MMWR Morb. Mortal. Wkly. Rep. 2023, 72, 190–198. [Google Scholar] [CrossRef] [PubMed]
  13. Alcendor, D.J.; Matthews-Juarez, P.; Smoot, D.; Edwards, A.; Hildreth, J.E.K.; Juarez, P.D. Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations. Vaccines 2023, 11, 906. [Google Scholar] [CrossRef] [PubMed]
  14. MacDonald, N.E. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef] [PubMed]
  15. Larson, H.J.; Schulz, W.S.; Tucker, J.D.; Smith, D.M. Measuring vaccine confidence: Introducing a global vaccine confidence index. PLoS Curr. 2015, 7. [Google Scholar] [CrossRef]
  16. Keselman, A.; Arnott Smith, C.; Wilson, A.J.; Leroy, G.; Kaufman, D.R. Cognitive and Cultural Factors That Affect General Vaccination and COVID-19 Vaccination Attitudes. Vaccines 2022, 11, 94. [Google Scholar] [CrossRef]
  17. Centers for Disease Control and Prevention. Vaccinate with Confidence: Strategy to Reinforce in COVID-19 Vaccines. Available online: https://www.cdc.gov/vaccines/covid-19/vaccinate-with-confidence.html (accessed on 16 November 2021).
  18. De Figueiredo, A.; Simas, C.; Karafillakis, E.; Paterson, P.; Larson, H.J. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study. Lancet 2020, 396, 898–908. [Google Scholar] [CrossRef]
  19. Karlsson, L.C.; Lewandowsky, S.; Antfolk, J.; Salo, P.; Lindfelt, M.; Oksanen, T.; Kivimäki, M.; Soveri, A. The association between vaccination confidence, vaccination behavior, and willingness to recommend vaccines among Finnish healthcare workers. PLoS ONE 2019, 14, e0224330. [Google Scholar] [CrossRef]
  20. Bedford, H.; Attwell, K.; Danchin, M.; Marshall, H.; Corben, P.; Leask, J. Vaccine hesitancy, refusal and access barriers: The need for clarity in terminology. Vaccine 2018, 36, 6556–6558. [Google Scholar] [CrossRef]
  21. Reich, J.A. “We are fierce, independent thinkers and intelligent”: Social capital and stigma management among mothers who refuse vaccines. Soc. Sci. Med. 2020, 257, 112015. [Google Scholar] [CrossRef]
  22. Lin, S. COVID-19 pandemic and im/migrants’ elevated health concerns in Canada: Vaccine hesitancy, anticipated stigma, and risk perception of accessing care. J. Immigr. Minor. Health 2022, 24, 896–908. [Google Scholar] [CrossRef]
  23. National Vaccine Advisory Committee. Assessing the State of Vaccine Confidence in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on 9 June 2015. Public Health Rep. 2015, 130, 573–595. [Google Scholar] [CrossRef] [PubMed]
  24. Larson, H.J.; de Figueiredo, A.; Xiahong, Z.; Schulz, W.S.; Verger, P.; Johnston, I.G.; Cook, A.R.; Jones, N.S. The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey. EBioMedicine 2016, 12, 295–301. [Google Scholar] [CrossRef] [PubMed]
  25. Lorini, C.; Collini, F.; Gasparini, F.; Paolini, D.; Grazzini, M.; Ierardi, F.; Galletti, G.; Zanobini, P.; Gemmi, F.; Bonaccorsi, G. Health Literacy, Vaccine Confidence and Influenza Vaccination Uptake among Nursing Home Staff: A Cross-Sectional Study Conducted in Tuscany. Vaccines 2020, 8, 154. [Google Scholar] [CrossRef] [PubMed]
  26. Frew, P.M.; Holloway, I.W.; Goldbeck, C.; Tan, D.; Wu, E.; Jauregui, J.; Fenimore, V.L.; Randall, L.A.; Lutz, C.S.; Mendel, J.; et al. Development of a measure to assess vaccine confidence among men who have sex with men. Expert. Rev. Vaccines 2018, 17, 1053–1061. [Google Scholar] [CrossRef]
  27. Frew, P.M.; Murden, R.; Mehta, C.C.; Chamberlain, A.T.; Hinman, A.R.; Nowak, G.; Mendel, J.; Aikin, A.; Randall, L.A.; Hargreaves, A.L.; et al. Development of a US trust measure to assess and monitor parental confidence in the vaccine system. Vaccine 2019, 37, 325–332. [Google Scholar] [CrossRef] [PubMed]
  28. Lazarus, J.V.; Wyka, K.; Rauh, L.; Rabin, K.; Ratzan, S.; Gostin, L.O.; Larson, H.J.; El-Mohandes, A. Hesitant or Not? The Association of Age, Gender, and Education with Potential Acceptance of a COVID-19 Vaccine: A Country-level Analysis. J. Health Commun. 2020, 25, 799–807. [Google Scholar] [CrossRef] [PubMed]
  29. Gilkey, M.B.; Magnus, B.E.; Reiter, P.L.; McRee, A.L.; Dempsey, A.F.; Brewer, N.T. The Vaccination Confidence Scale: A brief measure of parents’ vaccination beliefs. Vaccine 2014, 32, 6259–6265. [Google Scholar] [CrossRef]
  30. Larson, H.J.; Cooper, L.Z.; Eskola, J.; Katz, S.L.; Ratzan, S. Addressing the vaccine confidence gap. Lancet 2011, 378, 526–535. [Google Scholar] [CrossRef]
  31. Centers for Disease Control and Prevention. What Is Health Literacy? Available online: https://www.cdc.gov/healthliteracy/learn/index.html (accessed on 10 June 2021).
  32. Lorini, C.; Santomauro, F.; Donzellini, M.; Capecchi, L.; Bechini, A.; Boccalini, S.; Bonanni, P.; Bonaccorsi, G. Health literacy and vaccination: A systematic review. Hum. Vaccin. Immunother. 2018, 14, 478–488. [Google Scholar] [CrossRef]
  33. Feinberg, I.; Scott, J.Y.; Holland, D.P.; Lyn, R.; Scott, L.C.; Maloney, K.M.; Rothenberg, R. The Relationship between Health Literacy and COVID-19 Vaccination Prevalence during a Rapidly Evolving Pandemic and Infodemic. Vaccines 2022, 10, 1989. [Google Scholar] [CrossRef] [PubMed]
  34. Hurstak, E.E.; Paasche-Orlow, M.K.; Hahn, E.A.; Henault, L.E.; Taddeo, M.A.; Moreno, P.I.; Weaver, C.; Marquez, M.; Serrano, E.; Thomas, J. The mediating effect of health literacy on COVID-19 vaccine confidence among a diverse sample of urban adults in Boston and Chicago. Vaccine 2023, 41, 2562–2571. [Google Scholar] [CrossRef] [PubMed]
  35. Hahn, E.A.; Choi, S.W.; Griffith, J.W.; Yost, K.J.; Baker, D.W. Health Literacy Assessment Using Talking Touchscreen Technology (Health LiTT): A New Item Response Theory-Based Measure of Health Literacy. J. Health Commun. 2011, 16, 150–162. [Google Scholar] [CrossRef] [PubMed]
  36. Yost, K.J.; Webster, K.; Baker, D.W.; Jacobs, E.A.; Anderson, A.; Hahn, E.A. Acceptability of the talking touchscreen for health literacy assessment. J. Health Commun. 2010, 15, 80–92. [Google Scholar] [CrossRef] [PubMed]
  37. Yost, K.J.; Webster, K.; Baker, D.W.; Choi, S.W.; Bode, R.K.; Hahn, E.A. Bilingual health literacy assessment using the Talking Touchscreen/la Pantalla Parlanchina: Development and pilot testing. Patient Educ. Couns. 2009, 75, 295–301. [Google Scholar] [CrossRef] [PubMed]
  38. The Vaccine Confidence Project; London School of Hygiene and Tropical Medicine. The State of Vaccine Confidence; London School of Hygiene and Tropical Medicine: London, UK, 2015; p. 32. [Google Scholar]
  39. DiVirgilio, L.; Boshara, A.; Hunt, B.R.; Jacobs, J.; Just, K.; Johnson, A.K. A Community-Informed Approach to COVID-19 Vaccine Roll-Out in Under-served Areas in Chicago. Front. Public Health 2022, 10, 863125. [Google Scholar] [CrossRef]
  40. Assoumou, S.A.; Peterson, A.; Ginman, E.; James, T.; Pierre, C.M.; Hamilton, S.; Chapman, S.; Goldie, J.; Koenig, R.; Mendez-Escobar, E. Addressing inequities in SARS-CoV-2 vaccine uptake: The Boston Medical Center health system experience. Ann. Intern. Med. 2022, 175, 879–884. [Google Scholar] [CrossRef]
  41. Massachusetts Executive Office of Health and Human Services. Massachusetts COVID-19 Vaccination Phases. Available online: https://www.mass.gov/info-details/massachusetts-covid-19-vaccination-phases#phase-1- (accessed on 8 March 2023).
  42. Muthén, B.O.; Muthén, L.K.; Asparouhov, T. Regression and Mediation Analysis Using Mplus; Muthén & Muthén: Los Angeles, CA, USA, 2017. [Google Scholar]
  43. Shon, E.J.; Lee, L. Effects of Vaccine Literacy, Health Beliefs, and Flu Vaccination on Perceived Physical Health Status among Under/Graduate Students. Vaccines 2023, 11, 765. [Google Scholar] [CrossRef]
  44. Popa, A.D.; Enache, A.I.; Popa, I.V.; Antoniu, S.A.; Dragomir, R.A.; Burlacu, A. Determinants of the Hesitancy toward COVID-19 Vaccination in Eastern European Countries and the Relationship with Health and Vaccine Literacy: A Literature Review. Vaccines 2022, 10, 672. [Google Scholar] [CrossRef]
  45. Singh, K.; Lima, G.; Cha, M.; Cha, C.; Kulshrestha, J.; Ahn, Y.Y.; Varol, O. Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic. PLoS ONE 2022, 17, e0263381. [Google Scholar] [CrossRef]
  46. Walker, K.K.; Owens, H.; Zimet, G. “We fear the unknown”: Emergence, route and transfer of hesitancy and misinformation among HPV vaccine accepting mothers. Prev. Med. Rep. 2020, 20, 101240. [Google Scholar] [CrossRef]
  47. Willis, D.E.; Selig, J.P.; Andersen, J.A.; Hall, S.; Hallgren, E.; Williams, M.; Bryant-Moore, K.; McElfish, P.A. Hesitant but vaccinated: Assessing COVID-19 vaccine hesitancy among the recently vaccinated. J. Behav. Med. 2023, 46, 15–24. [Google Scholar] [CrossRef]
  48. Sun, L.X.; Chen, L.L.; Chen, W.Y.; Zhang, M.X.; Yang, M.G.; Mo, L.C.; Zhu, J.J.; Tung, T.H.; Li, F.P. Association between health behaviours and the COVID-19 vaccination: Risk compensation among healthcare workers in Taizhou, China. Hum. Vaccin. Immunother. 2022, 18, 2029257. [Google Scholar] [CrossRef]
  49. Gørtz, M.; Brewer, N.T.; Hansen, P.R.; Ejrnæs, M. The contagious nature of a vaccine scare: How the introduction of HPV vaccination lifted and eroded MMR vaccination in Denmark. Vaccine 2020, 38, 4432–4439. [Google Scholar] [CrossRef] [PubMed]
  50. Mignemi, G.; Panzeri, A.; Granziol, U.; Bruno, G.; Bertamini, M.; Vidotto, G.; Spoto, A. The mediating role of scientifical-medical satisfaction between COVID-19 conspiracy beliefs and vaccine confidence: A two-waves structural equation model. J. Behav. Med. 2023, 46, 201–211. [Google Scholar] [CrossRef] [PubMed]
  51. Badur, S.; Ota, M.; Öztürk, S.; Adegbola, R.; Dutta, A. Vaccine confidence: The keys to restoring trust. Hum. Vaccin. Immunother. 2020, 16, 1007–1017. [Google Scholar] [CrossRef] [PubMed]
  52. Larson, H.J.; Broniatowski, D.A. Why Debunking Misinformation Is Not Enough to Change People’s Minds About Vaccines. Am. J. Public Health 2021, 111, 1058–1060. [Google Scholar] [CrossRef] [PubMed]
  53. Broniatowski, D.A.; Dredze, M.; Ayers, J.W. “First Do No Harm”: Effective Communication About COVID-19 Vaccines. Am. J. Public Health 2021, 111, 1055–1057. [Google Scholar] [CrossRef] [PubMed]
  54. Syed, U.; Kapera, O.; Chandrasekhar, A.; Baylor, B.T.; Hassan, A.; Magalhães, M.; Meidany, F.; Schenker, I.; Messiah, S.E.; Bhatti, A. The Role of Faith-Based Organizations in Improving Vaccination Confidence & Addressing Vaccination Disparities to Help Improve Vaccine Uptake: A Systematic Review. Vaccines 2023, 11, 449. [Google Scholar]
  55. Pennycook, G.; Rand, D.G. Lazy, not biased: Susceptibility to partisan fake news is better explained by lack of reasoning than by motivated reasoning. Cognition 2019, 188, 39–50. [Google Scholar] [CrossRef]
  56. Basol, M.; Roozenbeek, J.; van der Linden, S. Good News about Bad News: Gamified Inoculation Boosts Confidence and Cognitive Immunity Against Fake News. J. Cogn. 2020, 3, 2. [Google Scholar] [CrossRef]
  57. Puri, N.; Coomes, E.A.; Haghbayan, H.; Gunaratne, K. Social media and vaccine hesitancy: New updates for the era of COVID-19 and globalized infectious diseases. Hum. Vaccin. Immunother. 2020, 16, 2586–2593. [Google Scholar] [CrossRef] [PubMed]
  58. Mheidly, N.; Fares, J. Leveraging media and health communication strategies to overcome the COVID-19 infodemic. J. Public Health Policy 2020, 41, 410–420. [Google Scholar] [CrossRef] [PubMed]
  59. Islam, M.S.; Sarkar, T.; Khan, S.H.; Mostofa Kamal, A.H.; Hasan, S.M.M.; Kabir, A.; Yeasmin, D.; Islam, M.A.; Amin Chowdhury, K.I.; Anwar, K.S.; et al. COVID-19-Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis. Am. J. Trop. Med. Hyg. 2020, 103, 1621–1629. [Google Scholar] [CrossRef] [PubMed]
  60. Austin, E.W.; Austin, B.W.; Willoughby, J.F.; Amram, O.; Domgaard, S. How Media Literacy and Science Media Literacy Predicted the Adoption of Protective Behaviors Amidst the COVID-19 Pandemic. J. Health Commun. 2021, 26, 239–252. [Google Scholar] [CrossRef]
Figure 1. Boxplots of vaccination status by vaccine confidence (a) and health literacy (b). The box’s centerline is the median; upper and lower quartile scores bound the box. Line extension “whiskers” extend from minimum to maximum scores.
Figure 1. Boxplots of vaccination status by vaccine confidence (a) and health literacy (b). The box’s centerline is the median; upper and lower quartile scores bound the box. Line extension “whiskers” extend from minimum to maximum scores.
Vaccines 11 01848 g001
Figure 2. Mediation model for health literacy, vaccine confidence, and COVID-19 vaccination. Note: values are rounded to two decimal places for visualization purposes.
Figure 2. Mediation model for health literacy, vaccine confidence, and COVID-19 vaccination. Note: values are rounded to two decimal places for visualization purposes.
Vaccines 11 01848 g002
Table 1. Participant demographic characteristic at baseline.
Table 1. Participant demographic characteristic at baseline.
Vaccinated
(n = 231)
Not Vaccinated
(n = 40)
Total
(n = 271)
Age (mean ± SD)50.5 (±16.6)48.3 (±13.4)50.2 (±16.2)
Gender (female, %)149 (64.5%)27 (67.5%)176 (65.0%)
Race and ethnicity (n, %)
  Asian10 (4.3%)010 (3.7%)
  Black82 (35.5%)25 (62.5%)107 (39.5%)
  Hispanic59 (25.5%)9 (23.1%)68 (25.2%)
  Mixed or other5 (2.2%)1 (2.5%)6 (2.2%)
  White75 (32.5%)5 (12.5%)80 (29.5%)
Education (n, %)
  ≤12th grade86 (37.2%)18 (45.0%)104 (38.4%)
  Some college44 (19.1%)11 (20.3%)55 (20.3%)
  College and above101 (43.7%)11 (27.5%)112 (41.3%)
Health literacy
(T Score mean ± SD)
54.0 (±8.4)50.8 (±8.5)53.5 (±8.5)
Vaccine confidence (aVCI)
  Baseline2.6 (±0.9)1.5 (±0.7)2.4 (±1.0)
  3 months2.9 (±0.9)1.8 (±0.9)2.8 (±1.0)
  6 months3.0 (±0.9)1.8 (±0.9)2.8 (±1.0)
Missing aVCI items49 (21.2%)11 (27.5%)60 (22.1%)
No participants identified as transgender or non-binary. Some college education includes an incomplete bachelor’s degree or an associate degree, or a qualification from a technical school.
Table 2. Mediation model estimates including direct and indirect effects.
Table 2. Mediation model estimates including direct and indirect effects.
PathEstimate95% Bootstrapped Confidence Intervals
Health literacyDirect effects
(continuous)Health literacy ==> Vaccination0.00−0.04, 0.04
Vaccine confidenceMediator ==> Vaccination
(aVCI, continuous)aVCI ==> Vaccination0.87 *0.44, 1.58
Mediator ==> Health literacy
aVCI ==> Health literacy0.04 *0.03, 0.06
Indirect effects on Vaccination
Health literacy ==> aVCI ==> Vaccination0.04 *0.02, 0.08
aVCI = Adapted Vaccine Confidence Index; Estimates are unstandardized. Estimates are starred (*) if the 95% confidence interval does not contain zero; Vaccine confidence is the mediator.
Table 3. Prediction of Vaccination by Health Literacy and Vaccine Confidence (baseline and over time).
Table 3. Prediction of Vaccination by Health Literacy and Vaccine Confidence (baseline and over time).
PredictorEstimate (Unstandardized)Estimate (Standardized)p95% CI
Health literacy0.000.010.40−0.02, 0.04
aVCI baseline1.200.85<0.001 ***0.64, 1.05
aVCI change−0.68−0.090.80−0.72, 0.54
Notes: aVCI = Adapted Vaccine Confidence Index; CI = confidence intervals; *** p < 0.001. Vaccination is the outcome.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hurstak, E.; Farina, F.R.; Paasche-Orlow, M.K.; Hahn, E.A.; Henault, L.E.; Moreno, P.; Weaver, C.; Marquez, M.; Serrano, E.; Thomas, J.; et al. COVID-19 Vaccine Confidence Mediates the Relationship between Health Literacy and Vaccination in a Diverse Sample of Urban Adults. Vaccines 2023, 11, 1848. https://doi.org/10.3390/vaccines11121848

AMA Style

Hurstak E, Farina FR, Paasche-Orlow MK, Hahn EA, Henault LE, Moreno P, Weaver C, Marquez M, Serrano E, Thomas J, et al. COVID-19 Vaccine Confidence Mediates the Relationship between Health Literacy and Vaccination in a Diverse Sample of Urban Adults. Vaccines. 2023; 11(12):1848. https://doi.org/10.3390/vaccines11121848

Chicago/Turabian Style

Hurstak, Emily, Francesca R. Farina, Michael K. Paasche-Orlow, Elizabeth A. Hahn, Lori E. Henault, Patricia Moreno, Claire Weaver, Melissa Marquez, Eloisa Serrano, Jessica Thomas, and et al. 2023. "COVID-19 Vaccine Confidence Mediates the Relationship between Health Literacy and Vaccination in a Diverse Sample of Urban Adults" Vaccines 11, no. 12: 1848. https://doi.org/10.3390/vaccines11121848

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop